Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
2006 Standout
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
2009 Standout
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
2009 StandoutNobel
Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Gene
2011 StandoutNobel
Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
1993
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
2016 Standout
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast
2008
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
2003 StandoutNobel
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor‐positive breast cancer
2006
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
2013 Standout
Growth and cell cycle regulation by isoflavones in human breast carcinoma cells
2002
Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique
1994
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
2010 Standout
QuPath: Open source software for digital pathology image analysis
2017 Standout
Transforming growth factor β1 is implicated in the failure of tamoxifen therapy in human breast cancer
1991
A view on drug resistance in cancer
2019 StandoutNature
Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.
1996
WT-1 is required for early kidney development
1993 Standout
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes
1996 Standout
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
2002
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
The benefits and harms of breast cancer screening: an independent review
2013
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
2008 Standout
The Edinburgh Randomized Trial of Breast Cancer Screening
1997
Prognostic Value of Residual Node Involvement in Operable Breast Cancer after Induction Chemotherapy
2002
Tumor suppressor genes
1991 Standout
Consort 2010 statement: extension to cluster randomised trials
2012 Standout
Estrogen and progesterone receptor concordance between primary and recurrent breast cancer
1994
The candidate Wilms' tumour gene is involved in genitourinary development
1990 Nature
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Pathological prognostic factors in breast cancer
1999 Standout
Estrogen Receptor Analysis for Breast Cancer
2005
Tissue microarrays for high-throughput molecular profiling of tumor specimens
1998 Standout
Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals
2003
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis
1990
Ductal Carcinoma In Situ, Complexities and Challenges
2004
Intraclass correlation coefficients for cluster randomized trials in primary care
2002
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
2005 Standout
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein
2010 StandoutNobel
American Cancer Society Guidelines for Breast Cancer Screening: Update 2003
2003
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
1993 Standout
A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples
1995
Comparison of the Performance of Screening Mammography, Physical Examination, and Breast US and Evaluation of Factors that Influence Them: An Analysis of 27,825 Patient Evaluations
2002 Standout
Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 50-59 Years
2000
Improving Mammography Screening Using Best Practices and Practice Enhancement Assistants: An Oklahoma Physicians Resource/Research Network (OKPRN) Study
2008
Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening
2005 Standout
Breast cancer metastasis: markers and models
2005 Standout
Gut Microbiota in Health and Disease
2010 Standout
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force
2002
Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study
2000
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
2006
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
2016 Standout
Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer.
1990
Factors that limit the quality, number and progress of randomised controlled trials.
1999
Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation
2016
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
1990 StandoutScience
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
2007 Standout
Screening for breast cancer with mammography
2013
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Decreased Breast Cancer Tumor Size, Stage, and Mortality in Rhode Island: An Example of a Well-Screened Population
2004
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
Benefits and Harms of Breast Cancer Screening
2015
Interventions for preventing falls in older people living in the community
2012 Standout
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of APM Forrest being referenced
RELATION BETWEEN IMMUNOCYTOCHEMICAL ESTIMATION OF OESTROGEN RECEPTOR IN ELDERLY PATIENTS WITH PRIMARY BREAST CANCER AND RESPONSE TO TAMOXIFEN
1989
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer
1989
The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up
1994
Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?
1990
p53 gene mRNA expression and chromosome 17p allele loss in breast cancer
1990
Primary systemic therapy for operable breast cancer - 10-year survival data after chemotherapy and hormone therapy
1997
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening
1999
The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy
1988